Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples